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Abstract
At present, lifestyle-related diseases are one of the most critical health issues worldwide. It has been reported that lipopolysaccharide derived 
from a Gram-negative bacteria (IP-PA1) symbiotic with wheat exhibited several advantageous biological effects, such as the reduction of plasma 
glucose levels in NOD mice and low-density lipoprotein (LDL) levels in WHHL rabbits. In this study, the beneficial effects on plasma glucose
and lipids of a tea (SI tea) consisting of IP-PA1 and Salacia (which contains an inhibitor of α-glucosidase) were investigated in the KK-Ay/TaJcl
type 2 diabetic model mice and in human subjects with premetabolic syndrome in a double-blind, randomized study. SI tea significantly decreased 
plasma glucose levels in KK-Ay/TaJcl mice. A clinical trial of SI tea was performed with 41 subjects between the ages of 40 and 69, who belonged
either to a high plasma glucose group (HG: FPG 100-125 mg/dl) or to a hyperlipidemia group (HL: TG ≥150 mg/dl, or LDL ≥120 mg/dl, 
or HDL < 40 mg/dl). These subjects ingested either Salacia without IP-PA1 (the control) or SI tea. Blood samples were collected at 0, 30, and
60 days after initiating SI tea treatment, and were measured for FPG, HbA1c, TG, LDL, and HDL. These results showed that SI tea reduced FPG
and HbA1c more rapidly than the control in the HL group, and also significantly improved LDL and HDL levels in the HG group. Thus, SI tea
may be helpful in preventing lifestyle-related diseases.
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Introduction9)
Lifestyle-related diseases, particularly diabetes, are rapidly 
increasing in advanced countries because of a change in lifestyle 
and social environment [1]. In Japan, the number of people 
suffering from diabetes is estimated to be approximately 22.1 
million, including those with suspected diabetes, and this value 
is predicted to increase in the future [2]. Over 95% of the cases 
are type 2 diabetes, a disease that is exacerbated by excessive 
dietary intake, lack of exercise, and increased stress [3]. It is 
clear that type 2 diabetes, which is accompanied by obesity and 
visceral fat accumulation, has a high risk of being associated 
with dyslipidemia and hypertension. While type 2 diabetes can 
be prevented by healthy diets and adequate exercise, the number 
of diabetics is increasing at present because of the difficulty in 
maintaining healthy diets or adequate exercise.
Salacia, which has been traditionally used in Indian Ayurvedic 
medicine, is effective for the prevention and treatment of diabetes 
[4]. The active ingredients are α-glucosidase inhibitors such as 
salasinol [5,6] and kotakanol [7]. These substances inhibit the 
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Salacia 
(Control)
Salacia +
IP-PA1
(SI tea)
Hoji tea 800 mg/g 655 mg/g
Salacia tea 200 mg/g  300 mg/g
Indigestible dextrin (IP-PA1) 0 20 mg/g 
Vitamin premix 0 25 mg/g 
Vitamin B1 : Dibenzoyl thiamine hydrochloride
(Thiamine hydrochloride)
0.32 mg/g
(0.19 mg/g)
Vitamin B2 : Riboflavin sodium phosphate
(Riboflavin)
0.27 mg/g
(0.21 mg/g)
Vitamin B6 : Pyridoxine hydrochloride 0.28 mg/g
Vitamin B12 : Cyanocobalamin 0.75 µg/g
Vitamin B3 : Nicotinamide 1.63 mg/g
Vitamin B5 : Calcium pantothenate
(Pantothenate)
0.96 mg/g
(0.88 mg/g)
Vitamin C : L-Ascorbic acid 7.5 mg/g
Other food additives
Table 1. Composition of experimental samples (mg/1 g)
breakdown of oligosaccharides and polysaccharides into mono-
saccharides by competitive inhibition of α-glucosidase activity 
within the lumen of the intestinal tract, which inhibits the rapid 
increase of plasma glucose after meals [8]. Diabetes is often 
associated with visceral fat accumulation, dyslipidemia, and 
hypertension [9,10]. Diabetics with these symptoms use different 
medicines for the treatment of each symptom. This gives rise 
to many treatment problems because of the synergistic side 
effects of the numerous medicines used [3]. For the prevention 
of diabetes, it is important to improve not only plasma glucose 
levels but to also decrease visceral fat accumulation, plasma lipid 
levels, and blood pressure levels. Salacia was reported to improve 
obesity and decrease triglyceride and cholesterol levels in mice 
and rats [11,12]. However, not much information on these effects 
in humans, except for a report on the improvement of plasma 
glucose levels, is available [8].
The innate immune system plays an essential role in the 
maintenance of animal health and the prevention of various 
diseases. The appropriate activation of macrophages plays a 
central role in innate immunity and functions not only for defense 
against infections but also for the maintenance of homeostasis 
(such as the elimination of foreign substances and metabolic 
control) [13]. We identified a lipopolysaccharide (LPS) (molecular 
weight approximately 5 kD) derived from a symbiotic Gram- 
negative bacteria, Pantea agglomerans [14]. This LPS was 
capable of activating macrophages in a water extract of wheat 
flour [15] and was designated IP-PA1, which is an abbreviation 
of “immune potentiator from P. agglomerans” [13]. Under 
certain limited conditions, LPS may act as an endotoxin, causing 
severe systemic inflammation, but more commonly, it has beneficial 
effects. LPS functions that have been recently discovered include 
the regulation of intestinal homeostasis, such as preventing 
enteric infectious diseases or the regulation of enteric immunity 
through interactions with gut-associated lymphoid tissue [16,17], 
modulation of proliferation and differentiation of the epithelial 
lineages [18], and regulation of angiogenesis [19] by oral 
administration. Thus, LPS is now recognized as an exohormone 
rather than simply an endotoxin [20].
It has been demonstrated that several foods contain Gram- 
negative bacteria or LPS. P. agglomerans is found not only in 
wheat but also in other food plants, such as rice [21], sweet 
potatoes [22], apples, and pears [23]. Moreover, it has been 
demonstrated that growth of P. agglomerans is mandatory for 
the fermentation of rye sourdough because it produces and 
provides folicacid to Lactobacillus. Considering this information 
and the long history of human intake, the bacteria P. agglomerans 
is believed to be nonpathogenic. In addition, in Europe, live P. 
agglomerans is used as a biocontrol agent for preventing fungal 
spoilage of fruit [24]. This suggests that IP-PA1 is a safe 
substance, and this has been confirmed with a conventional 
oral-administration safety test [13].
Previous studies in animals and human clinical trials reported 
suppressive effects of IP-PA1 on IgE-dependent allergies and an 
analgesic effect on the acetic acid writhing test [13]. In addition, 
IP-PA1 was also reported to delay the occurrence of type 1 
diabetes in mice [25] and decrease low-density lipoprotein (LDL) 
levels in familial hyperlipidemia [26]. However, it is not yet clear 
whether IP-PA1 is able to suppress type 2 diabetes. This is 
because the etiology and therapeutic approaches for diabetics are 
quite different for type 1 and type 2 diabetes. Also, it is not 
yet clear whether IP-PA1 improves diabetes associated with 
dyslipidemia. Thus, in this study, a tea (SI tea) was prepared 
that combined IP-PA1 (a regulator of immunity) and Salacia (an 
inhibitor of α-glucosidase), with the expectation that a beneficial 
effect would be observed in cases of diabetes and dyslipidemia. 
SI tea was first tested to determine whether it decreased the 
plasma glucose in KK-Ay/TaJcl mice (type 2 diabetes model 
mice). It was then tested to determine if it improved HbA1c 
values, blood glucose values, or LDL values in blood lipids of 
humans. This study used a randomized and double-blind design. 
Subjects had a routine general diet and test tea 2 times/day.
Subjects and Methods
Preparation of a mixture of Salacia and IP-PA1 (SI tea)
Salacia oblonga (Salacia) tea was prepared by Takama Co., 
Ltd, Japan, and the fermented flour containing 1% IP-PA1 was 
prepared by Macrophi Inc., Japan. IP-PA1 is a bacterial LPS 
that is derived from P. agglomerans. SI tea was a combination 
of Salacia tea, fermented flour, and vitamins. The C vitamin and 
B-group vitamins were premixed (B1, 0.32 mg/ml; B2, 0.27 
mg/ml; B6, 0.28 mg/ml; B12, 0.75 μg/ml; B3, 1.63 mg/ml; B5, 
0.96 mg/ml; and C, 7.5 mg/ml). The amount of vitamin premix 
was not expected to have any effect by itself on diabetes and 
hyperlipidemia [27,28]. In this study, 1 g of SI tea containing 
20 mg/g of fermented flour extract (200 μg/g as IP-PA1) was Kazue Nakata et al. 437
HG：High Plasma Glucose
(FPG: 100-125 mg/dl)
HL：Hyperlipemia
(TG:  ≥150 mg/dl or LDL: ≥
120 mg/dl or HDL：< 40 mg/dl)
Control SI tea Control SI tea
Number 6 7 14 14
Age 48.7 ± 6.5 49.7 ± 5.7 48.1 ± 8.2 49.7 ± 7.2
Height (cm） 165.5 ± 9.1 163.4 ± 9.6 163.6 ± 9.2 163.1 ± 9.0
Body weight (kg) 71.1 ± 8.6 63.5 ± 8.4 64.5 ± 9.7 61.7 ± 12.6
Body fat (%) 30.0 ± 7.5 24.5 ± 9.8 24.8 ± 3.7 26.3 ± 4.7
BMI 26.1 ± 3.7 23.9 ± 1.7 23.0 ± 3.0 24.0 ± 2.4
1) Values  are  mean ± SD.
Table 2. Characteristics of the subjects before examination
Fig. 1. Change in body weight by SI tea in KK-Ay/TaJcl mice. The values are 
mean ± SD.
used by dissolving in 100 ml of ambient or hot water. The control 
was  Salacia tea without the fermented flour extract (Table 1).
Animal experiments
Five-week-old male KK-Ay/TaJcl mice were obtained from 
CLEA Japan, Inc. (Tokyo, Japan), and the experiments lasted 
for 12 weeks after 1 week of acclimatization. The mice were 
maintained in a temperature-controlled room at 24 ± 2℃  and 
50%-70% humidity with a 12-h light cycle (light from 06:00 
to 18:00). The mice were housed (1 per cage), and had access 
to tap water and laboratory food ad libitum (CE-2; CLEA Japan, 
Inc.). The mice were divided into three groups: distilled water 
(DW; n = 10), Salacia tea (control; n = 10), and SI tea (n = 11). 
The oral daily dose administered for IP-PA1 was 10 μg/kg body 
weight and for Salacia was 3 mg/kg body weight, accomplished 
by drinking SI tea for 12 weeks. Body weight and fasting plasma 
glucose (FPG) levels were measured every week during the 
course of the study for 12 weeks. FPG was measured after an 
overnight fast of at least 10 hours. Mice were immobilized with 
a stereotaxic apparatus. Blood glucose levels were determined 
by measuring the absorbance using an Accu-Chek Aviva (Roche). 
This study was approved by the Laboratory Animal Committee 
of Kagawa University; the mice were maintained in accordance 
with the Guide for Animal Experiments at Kagawa University.
Clinical study subjects
Forty-seven subjects (age range, 40-69 years) from a clinic 
in Kagawa participated in this study. The high-plasma glucose 
(HG) group consisted of 14 subjects whose FPG levels were 
100-125 mg/dl; the hyperlipidemia (HL) group consisted of 33 
subjects whose triglyceride (TG) levels were higher than 150 
mg/dl, or whose LDL levels were higher than 120 mg/dl, or 
whose HDL levels were lower than 40 mg/dl (Table 2). This 
study was randomized in each group, and conducted using a 
double-blinded design. Of these, 3 subjects being treated for 
hyperlipidemia or hypertension were excluded from the study 
because of their poor physical condition or deconditioning during 
the intake period. The study protocol was approved by the Ethics 
Committee of the Non-profit Organization, Linking Setouchi 
Innate Immune Network, and was carried out in accordance with 
the principles of the Declaration of Helsinki. Procedures were 
carefully explained to the participants, and written informed 
consent was obtained from them. 
Study procedure
This study initiated on October 1, 2008, and continued for 60 
days. It was conducted by a double-blinded method, randomized 
by envelopes. Subjects ingested the routine general diet and test 
tea 2 times/day, and their intake time and physical conditions 
were recorded each day. To measure glucose metabolism markers 
(FPG and HbA1c) and lipid metabolism markers (TG, LDL, and 
HDL), blood samples were collected on days 0, 30, and 60. 
Subjects fasted after 22:00 on days before blood collection.
Statistical analysis
Data are expressed as mean ± SD. Statistical analyses were 
performed using Excel Statistics 2008 (Microsoft, USA). In the 
animal experiment, differences between the DW group, the 
Salacia tea control group, and the SI tea group were analyzed 
using the Tukey-Kramer multiple comparison post tests. In a 
clinical trial, differences between day 0 and day 30, or day 0 
and day 60, were compared using the Tukey-Kramer multiple 
comparison post tests. Differences with P< 0.05 were considered 
to be significant.
Results
The beneficial effect of SI tea on plasma glucose levels in type 
2 diabetic mice
Before these clinical experiments, antidiabetic effects of SI tea 
were investigated using KK-Ay/TaJcl type 2 diabetic model mice. 
The mice had free access to tap water and laboratory food. The 
body weights for each group before intake were as follows: the 
DW group, 26.39 ± 1.07 g; the control group, 26.69 ± 1.19 g; 438 Dietrary effect of Salacia  and IP-PA1 combination tea
Fig. 2. Change in plasma glucose levels by SI tea in KK-Ay/TaJcl mice. The 
values are means±SD. a) Differences between the DW group and the Salacia tea 
c o n t r o l  g r o u p ,  o r  t h e  D W  g r o u p  a n d  t h e  S I  t e a  g r o u p  w e r e  a n a l y ze d  u s i n g  t h e  
Tukey-Kramer multiple comparison post tests at P < 0.01. b) Differences between 
the  Salacia  tea  control  group  and  the  SI  tea  group  were  analyzed  using  the 
Tukey-Kramer  multiple  comparison  post-tests  at  SI,  P < 0.01.
Day 0 Day 30 Day 60
Body fat (％) HG: Control 30.0 ± 7.5 30.7 ± 9.0 29.8 ± 7.9
HG: SI tea 24.5 ± 9.8 27.1 ± 10.5 27.1 ± 10.5
HL: Control 24.8 ± 3.7 26.1 ± 4.0 26.5 ± 4.4
HL: SI tea 26.3 ± 4.7 27.8 ± 5.0 28.9 ± 5.8
BMI HG: Control 26.5 ± 3.9 26.5 ± 4.4 26.5 ± 4.3
HG: SI tea 23.9 ± 4.0 24.1 ± 3.7 24.2 ± 3.6
HL: Control 23.0 ± 3.0 23.2 ± 2.9 23.1 ± 3.0
HL: SI tea 24.0 ± 2.4 24.3 ± 2.3 24.2 ± 2.4
FPG (mg/dl) HG: Control 105.2 ± 7.6 102.7 ± 11.0 98.7 ± 6.3*
HG: SI tea 105.4 ± 5.8 103.1 ± 9.4 103.7 ± 16.2
HL: Control 92.3 ± 3.0 89.9 ± 7.5 87.2 ± 6.2*
HL: SI tea 91.8 ± 5.5 87.1 ± 5.5** 85.0 ± 6.7**
HbA1c (%) HG: Control 5.2 ± 0.6 5.1 ± 0.6 5.0 ± 0.6
HG: SI tea 5.2 ± 0.3 5.1 ± 0.2 5.0 ± 0.4
HL: Control 4.9 ± 0.3 4.9 ± 0.2 4.9 ± 0.3
HL: SI tea 5.0 ± 0.2 4.9 ± 0.1* 4.9 ± 0.2*
TG (mg/dl) HG: Control 130.7 ± 47.3 126.0 ± 62.1 133.0 ± 47.9
HG: SI tea 102.6 ± 37.4 78.0 ± 21.1 103.4 ± 41.7
HL: Control 152.5 ± 80.3 147.1 ± 95.7 115.4 ± 52.5
HL: SI tea 134.5 ± 64.9 132.4 ± 67.8 124.9 ± 64.6
LDL (mg/dl) HG: Control 140.0 ± 26.9 137.5 ± 25.4 130.7 ± 21.6
HG: SI tea 136.1 ± 29.9 135.3 ± 37.0 122.1 ± 34.6*
HL: Control 140.8 ± 31.7 141.1 ± 41.6 134.1 ± 29.9
HL: SI tea 148.1 ± 32.2 147.7 ± 44.3 142.1 ± 39.1*
HDL (mg/dl) HG: Control 57.2 ± 10.3 57.0 ± 11.7 53.5 ± 12.3
HG: SI tea 54.7 ± 13.7 58.1 ± 13.0* 56.0 ± 19.2
HL: Control 55.0 ± 13.1 57.4 ± 13.9 58.3 ± 15.7
HL:SI tea 61.1 ± 12.5 59.0 ± 13.6 59.0 ± 10.8
1) Values  are  mean ± SD.
2) Normal range: body fat (％): male, 17%-23%; female, 20%-27%; BMI: 18.5-< 25; 
FPG (mg/dl): <110 mg/dl; HbA1c (%): 4.4%-5.8%; TG (mg/dl): <150 mg/dl; LDL 
(mg/dl):  < 120  mg/dl;  HDL  (mg/dl):  ≥40  mg/dl
3) P  value  is  for  treatment  differences  in  30  day-  or  60  day-values a d ju s t e d  f o r 
variation in 0 day-values using the Tukey-Kramer Multiple Comparison post tests. 
*P < 0.05,  **P < 0.01. 
Table 3. Change of measured values in the subjects
and the SI tea group 26.84 ± 1.81 g. After 12 weeks, the body 
weights for each group increased in all groups as follows: the 
DW group, 45.64 ± 3.45 g; the control group, 45.47 ± 3.22 g; 
and the SI tea group 44.75 ± 3.18 g (Fig. 1). FPG levels for each 
group before intake were as follows: the DW group, 93.6 ± 17.6 
mg/dl; the control group, 95.7 ± 18.1 mg/dl; and the SI tea group, 
103.5 ± 60.9 mg/dl. After 2 weeks from the start of the 
experiment, FPG levels for each group were as follows: DW
> control > SI tea, and this order did not change during the rest 
of the experiment as shown in Fig. 2. The average FPG level 
of each group in all periods of intake was: DW group, 118.5
± 24.0 mg/dl; control group, 108.9 ± 24.0 mg/dl; and SI tea 
group, 98.5 ± 21.5 mg/dl (Fig. 2). FPG levels in DW and the 
control (Salacia tea) group showed a tendency to increase; while 
in the SI tea group, they decreased slightly. These results indicate 
that a combination of fermented wheat flour with IP-PA1 and 
Salacia effectively decreased FPG in type 2 diabetic mice more 
than with Salacia tea alone.
Changes in metabolism markers in humans
The above-mentioned animal data indicates that SI tea 
improved blood glucose levels in KK-Ay/TaJcl type 2 diabetic- 
model mice more than Salacia tea. Moreover, we previously 
found that IP-PA1 decreases LDL levels in hyperlipidemic rabbits 
(WHHL) [26]. We then investigated the anti-diabetic effect of 
SI tea in human volunteers with high-plasma glucose (HG group) 
or hyperlipidemia (HL group). Characteristics of each group 
before the clinical trial are shown in Table 3. While this study 
was randomized to the control or SI tea in the HG group and 
HL group, the body fat in the HG control group was higher than 
in other groups. However, the change of body fat was not 
significantly different for all groups.
Changes in glucose metabolism markers
First, the effect of SI tea on the improvement of FPG levels 
in human HG and HL groups was examined. Fig. 3 shows the 
change in glucose metabolism markers over the 60-day period. 
FPG levels in each group before initiating the intake were as 
follows: the HG control group, 105.2 ± 7.6 mg/dl; the HG SI 
tea group, 105.4 ± 5.8 mg/dl; the HL control group, 92.3 ± 3.0 
mg/dl; and the HL SI tea group, 91.8 ± 5.5 mg/dl. Sixty days 
after initiating the intake of teas, the FPG values were as follows: 
the HG control group, 98.7 ± 6.3 mg/dl; the HG SI tea group, 
103.7 ± 16.2 mg/dl; the HL control group, 87.2 ± 6.2 mg/dl; and 
the HL SI tea group, 85.0 ± 6.7 mg/dl. Thus, the level of FPG 
in the SI tea group did not change. However, the FPG level 
of the HL group that consumed SI tea showed a significant 
decrease earlier than the control. HbA1c levels in each group 
before initiating the intake were as follows: the HG control group, 
5.2% ± 0.6%; the HG SI tea group, 5.2% ± 0.3%; the HL control Kazue Nakata et al. 439
Fig. 3. Change in glucose metabolism markers. Effect of SI tea on FPG and 
HbA1c in humans during a 60-day period. ■:  HG  control;  ♦:  HG  SI  tea;  □: 
HL control; ◇: HL SI tea. Values are mean ± SD. Differences in 30 day- or 60 
day-values adjusted for variation in 0 day-values using the Tukey-Kramer multiple 
comparison  post-tests.  *P < 0.05,  **P < 0.01.
Fig. 4. Change in lipid metabolism markers. Effect of SI tea on TG, LDL, and 
HDL in humans during a 60-day period. ■: HG control; ♦: HG SI tea; □: HL 
control;  ◇:  HL  SI  tea.  Values  are  means ± SD.  Differences  in  30  day-  or  60 
day-values adjusted for variation in 0 day-values using the Tukey-Kramer multiple 
comparison  post-tests.  *P < 0.05,  **P < 0.01.
group, 4.9% ± 0.3%; and the HL SI tea group, 5.0% ± 0.2%. 
Sixty days after the intake of teas, the HbA1c values were as 
follows: the HG control group, 5.0% ± 0.6%; the HG SI tea 
group, 5.0% ± 0.4%; the HL control group, 4.9% ± 0.3%; and 
the HL SI tea group, 4.9% ± 0.2%. As with FPG, the level of 
HbA1c in the HG group was almost the same in the control 
and SI tea groups. In contrast, the level of HbA1c in the HL 
group significantly decreased after 30 days in the SI tea group. 
These results suggest that IP-PA1 promoted a decrease of this 
glucose metabolism marker when combined with Salacia tea. In 
addition, this combination effect of IP-PA1 with Salacia was 
more prominent in the HL group than in the HG group.
Changes in lipid metabolism markers
Next, we investigated the changes in lipid metabolism markers. 
Table 3 shows that before the experiment, the TG level in the 
HL control group was high, 152.5 ± 80.3 mg/dl. Also, the LDL 
level was high in all of groups: the HG control group, 140.0
± 26.9 mg/dl; the HG SI tea group, 136.1 ± 29.9 mg/dl; the HL 
control group, 140.8 ± 31.7 mg/dl; and the HL SI tea group, 148.1
± 32.2 mg/dl. The TG level did not change in any of the groups. 
However, the TG level in the HL group that consumed SI tea 
and  Salacia tea showed a tendency to decrease (Fig. 4). The 
LDL level for those who consumed SI tea decreased both in 
the HG group and the HL group after 60 days, 122.1 ± 34.6 mg/dl 
and 142.1 ± 39.1 mg/dl, respectively. The HDL level significantly 
increased in the HG group after consuming SI tea for 30 days 
(58.1 ± 13.0 mg/dl). As a result of the study on TG, LDL, and 
HDL values, it was confirmed that LDL values, which were 
higher than normal levels before the trial, had decreased significantly 
after administration of SI tea. 
Discussion
In Japan, over 95% of diabetics have type 2 diabetes. While 
suppressive effects of IP-PA1 on the occurrence of diabetes 
development in NOD type 1 diabetic-model mice have been 
reported [25], the effect of IP-PA1 on type 2 diabetes is still 
unclear. This is why we investigated the beneficial effects of 
SI tea on FPG levels in a type 2 diabetic mouse model (KK- 
Ay/TaJcl mice), which is based on a lifestyle disease. The result 
of body weight change was confirmed to increase in all groups, 
and it was not different among the groups. It was reported that 
there was a slight weight loss in mice and rats that were fed 
with Salacia [11,12]. In another study, after Salacia intake for 
3 weeks, it was reported that body weight did not differ between 
the control and Salacia groups [29]. Thus, the addition of IP-PA1 
did not induce abrupt body weight change similar to Salacia 
alone, and if our study was prolonged, it may have been different 
between the control group and the SI group. The results indicated 
that levels of FPG in DW and control (Salacia tea) groups 
gradually tended to increase but slightly decreased in the SI tea 
group (Fig. 2). Since FPG levels of the control Salacia tea group 
showed a tendency to increase, this suggests that SI tea has the 440 Dietrary effect of Salacia  and IP-PA1 combination tea
potential to improve type 2 diabetes and that this effect is superior 
to  Salacia tea alone. 
Salacia tea reduces high blood glucose levels because it 
contains salacinol and kotalanol, both of which are inhibitors 
of α-glucosidase. It is known that guava polyphenol, mulberry, 
and Gymnema also have similar inhibitory activity against α
-glucosidase but Salacia is the most effective [30]. While the 
antidiabetic mechanism of IP-PA1, a macrophage-activating 
substance, remain elusive, macrophage activation has been 
reported to be effective in treatment of type 1 and type 2 diabetes 
[31-34]. 
Type 1 diabetes is caused by the progressive loss of insulin- 
producing pancreatic β cells by inducing auto-reactive cytotoxic 
T lymphocytes [35]. Moreover, it has recently been demonstrated 
that killer T cells initiate an inflammatory cascade within the 
adipose tissue, and that this induces insulin resistance in type 
2 diabetes [36,37]. Therefore, type 1 and type 2 diabetes are 
similar inflammatory diseases. 
Recently, two different states of macrophages have been 
defined: the M1 (or classically activated) and M2 (or alternatively 
activated) macrophages [38]. M1-activated macrophages typically 
produce pro-inflammatory cytokines (tumor necrosis factor 
(TNF)-α, interleukin (IL)-1β). M2 macrophages increase anti-infla-
mmatory cytokines (IL-10) and arginase 1 activity. Functionally, 
M2 macrophages down-regulate inflammatory responses and 
promote tissue repair. Adipose tissue macrophages in obesity 
induce an inflammatory reaction (such as TNF secretion) in 
cytokines, whereas macrophages in healthy adipose tissue release 
anti-inflammatory cytokines such as IL-10 and TGF-β [39,40]. 
We found an anti-inflammatory response to IP-PA1 in atopic 
dermatitis experiments [13]. Porta et al. [41] reported that M2 
macrophages are induced by a small amount of LPS for a long 
period. In animal models, nicotine treatment reduces the incidence 
of type 1 diabetes animal models by increasing the pancreatic 
levels of the M2 cytokines IL-4 and IL-10 [42]. These results 
suggest that M2 type macrophages released IL-10 from 
macrophage activated by IP-PA1, suppressing the inflammatory 
response. Details of the mode of action for the anti-diabetic effect 
of IP-PA1 requires further investigation, such as the measurement 
of diabetes-associated markers (TNF-α, IL-1β  and IL-10), 
insulin, and leptin.
The improvement in human plasma glucose levels is shown 
in Fig. 3. To examine the preventive effect on diabetes, non- 
diabetic subjects were chosen with high FPG levels (HG: FPG 
100-125 mg/dl). The results indicate that SI tea did not change 
FPG levels, although it showed a tendency to reduce HbA1c 
levels. Type 2 diabetes is often accompanied by obesity and 
dyslipidemia. The most common pattern of diabetes is chara-
cterized by the secretion of TNF-α from adipose tissue because 
of dyslipidemia, which leads to impaired insulin sensitivity and 
impaired glucose tolerance (IGT) [43]. As stated above, in 
healthy individuals with normal body weight, macrophages are 
present in moderate quantities in adipose tissue, in which 
inflammatory signals are low or nonexistent. On the other hand, 
the adipose tissue macrophages in obese individuals produce 
pro-inflammatory cytokines and induce IGT [44]. It is suggested 
that macrophages are either suppressors or enhancers in the 
development of diabetes. However, several issues are still unclear 
about the mechanism that regulates the differentiation of macro-
phages, and the relationship between the onset of diabetes and 
macrophage behavior.
Our previous study showed that the serum cholesterol level 
in WHHL rabbits decreased with the uptake of IP-PA1 [26]. 
Kishino et al. [12] indicated that Salacia improves obesity and 
decreases plasma lipid levels by lipase inhibition in mice and 
rats. Thus, it was expected that herbal tea containing Salacia 
and IP-PA1 would improve not only plasma glucose but also 
serum cholesterol levels in subjects with dyslipidemia. We 
investigated the SI tea effects on plasma glucose levels and 
plasma lipid levels in a group of subjects which consisted not 
only of a high glucose group but also a high lipid group (TG: 
≥150 mg/dl, or LDL: ≥120 mg/dl, or HDL: < 40 mg/dl). As 
shown in Fig. 3, significant changes in levels of FPG and HbA1c 
were observed in the HL group as in the HG group. Especially, 
the FPG level of the HL group that consumed SI tea was 
significantly lower than that of the HG group. In this study, the 
FPG level of the HL group stayed within the normal level. 
However, even if the FPG level is normal, Japanese people tend 
to develop IGT because their insulin secretion ability is lower 
than in other ethnic populations [45]. High IGT levels increase 
the risk of occurrence of diabetes and arteriosclerosis to a greater 
extent than high FPG levels [46,47]. Moreover, a correlation 
between a decrease in IGT and FPG was reported [48]. Since 
a significant effect of decreasing plasma glucose levels due to 
SI tea was observed in the HL group but not the HG group, 
it is believed that SI tea may be effective for IGT. This would 
not be obvious from the FPG values alone. SI tea significantly 
reduced LDL levels in the plasma lipid of both HG and HL 
groups. In addition, there was a significant increase in the HDL 
level of HG groups that consumed SI tea. LDL levels of all 
subjects from all groups before the experiment were high (Table 
3). While in the present study, a change in obesity was not 
observed with Salacia (Table 3), Akase et al. [11] reported that 
Salacia decreased body weight and visceral fat in mice and rats. 
The difference in the results was most likely because of the 
difference between a regulated rodent model and a human 
experiment in which it is difficult to control food and life style.
In conclusion, SI tea not only decreased FPG levels more 
effectively than Salacia tea alone but it also improved LDL 
values. Thus, it can be anticipated that SI tea will be used as 
a preventive food for lifestyle-related diseases, such as diabetes, 
obesity, and dyslipidemia.Kazue Nakata et al. 441
References
1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence 
of diabetes: estimates for the year 2000 and projections for 2030. 
Diabetes Care  2004;27:1047-53.
2. Adachi M, Yamaoka K, Watanabe M, Nishikawa M, Hida E, 
Kobayashi I, Tango T. Effects of lifestyle education program for 
type 2 diabetes patients in clinics: study design of a cluster 
randomized trial. BMC Public Health 2010;10:742.
3. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the 
paradox between visceral and subcutaneous fat. Curr Diabetes 
Rev 2006;2:367-73.
4. Wolf BW, Weisbrode SE. Safety evaluation of an extract from 
Salacia oblonga. Food Chem Toxicol 2003;41:867-74.
5. Yoshikawa M, Morikawa T, Matsuda H, Tanabe G, Muraoka O. 
Absolute stereostructure of potent alpha-glucosidase inhibitor, 
Salacinol, with unique thiosugar sulfonium sulfate inner salt structure 
from Salacia reticulata. Bioorg Med Chem 2002;10:1547-54.
6. Ghavami A, Johnston BD, Pinto BM. A new class of glycosidase 
inhibitor: synthesis of salacinol and its stereoisomers. J Org 
Chem 2001;66:2312-7.
7. Yoshikawa M, Murakami T, Yashiro K, Matsuda H. Kotalanol, 
a potent alpha-glucosidase inhibitor with thiosugar sulfonium 
sulfate structure, from antidiabetic ayurvedic medicine Salacia 
reticulata. Chem Pharm Bull (Tokyo) 1998;46:1339-40.
8. Williams JA, Choe YS, Noss MJ, Baumgartner CJ, Mustad VA. 
Extract of Salacia oblonga lowers acute glycemia in patients with 
type 2 diabetes. Am J Clin Nutr 2007;86:124-30.
9. Deguchi Y, Miyazaki K. Anti-hyperglycemic and anti-hyperlipidemic 
effects of guava leaf extract. Nutr Metab (Lond) 2010;7:9.
10. Blonde L. Current antihyperglycemic treatment strategies for 
patients with type 2 diabetes mellitus. Cleve Clin J Med 2009;76 
Suppl 5:S4-11.
11. Akase T, Shimada T, Harasawa Y, Ikeya Y, Nagai E, Iizuka S, 
Nakagami G, Iizaka S, Sanada H, Aburada M. Preventive effects 
of Salacia reticulata on obesity and metabolic disorders in TSOD 
mice. Evid Based Complement Alternat Med 2009. [Epub ahead 
of print].
12. Kishino E, Ito T, Fujita K, Kiuchi Y. A mixture of the Salacia 
reticulata (Kotala himbutu) aqueous extract and cyclodextrin 
reduces the accumulation of visceral fat mass in mice and rats 
with high-fat diet-induced obesity. J Nutr 2006;136:433-9.
13. Kohchi C, Inagawa H, Nishizawa T, Yamaguchi T, Nagai S, 
Soma G. Applications of lipopolysaccharide derived from Pantoea 
agglomerans (IP-PA1) for health care based on macrophage 
network theory. J Biosci Bioeng 2006;102:485-96.
14. Tsukioka D, Nishizawa T, Miyase T, Achiwa K, Suda T, Soma 
G, Mizuno D. Structural characterization of lipid A obtained 
from Pantoea agglomerans lipopolysaccharide. FEMS Microbiol 
Lett 1997;149:239-44.
15. Inagawa H, Nishizawa T, Tsukioka D, Suda T, Chiba Y, Okutomi 
T, Morikawa A, Soma GI, Mizuno D. Homeostasis as regulated 
by activated macrophage. II. LPS of plant origin other than wheat 
flour and their concomitant bacteria. Chem Pharm Bull (Tokyo) 
1992;40:994-7.
16. Braun-Fahrländer C, Riedler J, Herz U, Eder W, Waser M, Grize 
L, Maisch S, Carr D, Gerlach F, Bufe A, Lauener RP, Schierl 
R, Renz H, Nowak D, von Mutius E; Allergy and Endotoxin 
Study Team. Environmental exposure to endotoxin and its relation 
to asthma in school-age children. N Engl J Med 2002;347: 
869-77.
17. Cebra JJ. Influences of microbiota on intestinal immune system 
development. Am J Clin Nutr 1999;69:1046S-1051S.
18. Uribe A, Alam M, Midtvedt T, Smedfors B, Theodorsson E. 
Endogenous prostaglandins and microflora modulate DNA 
synthesis and neuroendocrine peptides in the rat gastrointestinal 
tract. Scand J Gastroenterol 1997;32:691-9.
19. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation 
of intestinal angiogenesis by indigenous microbes via Paneth 
cells. Proc Natl Acad Sci U S A 2002;99:15451-5.
20. Marshall JC. Lipopolysaccharide: an endotoxin or an exogenous 
hormone? Clin Infect Dis 2005;41 Suppl 7:S470-80.
21. Miao Y, Zhou J, Chen C, Shen D, Song W, Feng Y. In vitro 
adsorption revealing an apparent strong interaction between 
endophyte Pantoea agglomerans YS19 and host rice. Curr 
Microbiol 2008;57:547-51.
22. Asis CA Jr, Adachi K. Isolation of endophytic diazotroph 
Pantoea agglomerans and nondiazotroph Enterobacter asburiae 
from sweetpotato stem in Japan. Lett Appl Microbiol 2004;38: 
19-23.
23. Pusey PL. Effect of nectar on microbial antagonists evaluated for 
use in control of fire blight of pome fruits. Phytopathology 
1999;89:39-46.
24. Stockwell VO, Johnson KB, Sugar D, Loper JE. Antibiosis 
contributes to biological control of fire blight by Pantoea 
agglomerans strain Eh252 in orchards. Phytopathology 2002;92: 
1202-9.
25. Iguchi M, Inagawa H, Nishizawa T, Okutomi T, Morikawa A, 
Soma GI, Mizuno D. Homeostasis as regulated by activated 
macrophage. V. Suppression of diabetes mellitus in non-obese 
diabetic mice by LPSw (a lipopolysaccharide from wheat flour). 
Chem Pharm Bull (Tokyo) 1992;40:1004-6.
26. Okutomi T, Nishizawa T, Inagawa H, Takano T, Morikawa A, 
Soma G, Mizuno D. Homeostasis as regulated by activated 
macrophage. VII. Suppression of serum cholesterol level by 
LPSw (a lipopolysaccharide from wheat flour) in WHHL 
(Watanabe heritable hyperlipidemic) rabbit. Chem Pharm Bull 
(Tokyo) 1992;40:1268-70.
27. Lu Q, Björkhem I, Wretlind B, Diczfalusy U, Henriksson P, 
Freyschuss A. Effect of ascorbic acid on microcirculation in 
patients with Type II diabetes: a randomized placebo-controlled 
cross-over study. Clin Sci (Lond) 2005;108:507-13.
28. Earnest CP, Wood KA, Church TS. Complex multivitamin 
supplementation improves homocysteine and resistance to LDL-C 
oxidation. J Am Coll Nutr 2003;22:400-7.
29. Im R, Mano H, Nakatani S, Shimizu J, Wada M. Safety 
evaluation of the aqueous extract Kothala himbutu (Salacia 
reticulata) stem in the hepatic gene expression profile of normal 
mice using DNA microarrays. Biosci Biotechnol Biochem 2008; 
72:3075-83.
30. Benalla W, Bellahcen S, Bnouham M. Antidiabetic medicinal 
plants as a source of alpha glucosidase inhibitors. Curr Diabetes 
Rev 2010;6:247-54.
31. Geutskens SB, Otonkoski T, Pulkkinen MA, Drexhage HA, 
Leenen PJ. Macrophages in the murine pancreas and their 
involvement in fetal endocrine development in vitro. J Leukoc 
Biol 2005;78:845-52.
32. Jun HS, Yoon CS, Zbytnuik L, van Rooijen N, Yoon JW. The 
role of macrophages in T cell-mediated autoimmune diabetes in 
nonobese diabetic mice. J Exp Med 1999;189:347-58.442 Dietrary effect of Salacia  and IP-PA1 combination tea
33. Jansen A, Homo-Delarche F, Hooijkaas H, Leenen PJ, Dardenne 
M, Drexhage HA. Immunohistochemical characterization of 
monocytes-macrophages and dendritic cells involved in the 
initiation of the insulitis and beta-cell destruction in NOD mice. 
Diabetes 1994;43:667-75.
34. Meijer K, de Vries M, Al-Lahham S, Bruinenberg M, Weening 
D, Dijkstra M, Kloosterhuis N, van der Leij RJ, van der Want 
H, Kroesen BJ, Vonk R, Rezaee F. Human primary adipocytes 
exhibit immune cell function: adipocytes prime inflammation 
independent of macrophages. PLoS One 2011;6:e17154.
35. Wong FS, Visintin I, Wen L, Flavell RA, Janeway CA Jr CD8 
T cell clones from young nonobese diabetic (NOD) islets can 
transfer rapid onset of diabetes in NOD mice in the absence of 
CD4 cells. J Exp Med 1996;183:67-76.
36. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, 
Ohsugi M, Otsu M, Hara K, Ueki K, Sugiura S, Yoshimura K, 
Kadowaki T, Nagai R. CD8+ effector T cells contribute to 
macrophage recruitment and adipose tissue inflammation in 
obesity. Nat Med 2009;15:914-20.
37. Hotamisligil GS. Inflammation and metabolic disorders. Nature 
2006;444:860-7.
38. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. 
Macrophage polarization: tumor-associated macrophages as a 
paradigm for polarized M2 mononuclear phagocytes. Trends 
Immunol 2002;23:549-55.
39. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic 
switch in adipose tissue macrophage polarization. J Clin Invest 
2007;117:175-84.
40. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, 
Henson PM. Macrophages that have ingested apoptotic cells in 
vitro inhibit proinflammatory cytokine production through autocrine/ 
paracrine mechanisms involving TGF-beta, PGE2, and PAF. J 
Clin Invest 1998;101:890-8.
41. Porta C, Rimoldi M, Raes G, Brys L, Ghezzi P, Di Liberto D, 
Dieli F, Ghisletti S, Natoli G, De Baetselier P, Mantovani A, Sica 
A. Tolerance and M2 (alternative) macrophage polarization are 
related processes orchestrated by p50 nuclear factor kappaB. Proc 
Natl Acad Sci U S A 2009;106:14978-83.
42. Mabley JG, Pacher P, Southan GJ, Salzman AL, Szabó C. 
Nicotine reduces the incidence of type I diabetes in mice. J 
Pharmacol Exp Ther 2002;300:876-81.
43. Petersen AM, Pedersen BK. The anti-inflammatory effect of 
exercise. J Appl Physiol 2005;98:1154-62.
44. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation 
by nutrients and inflammation. J Clin Invest 2008;118:2992- 
3002.
45. Fukushima M, Usami M, Ikeda M, Nakai Y, Taniguchi A, 
Matsuura T, Suzuki H, Kurose T, Yamada Y, Seino Y. Insulin 
secretion and insulin sensitivity at different stages of glucose 
tolerance: a cross-sectional study of Japanese type 2 diabetes. 
Metabolism 2004;53:831-5.
46. Xu L, Jiang CQ, Lam TH, Cheng KK, Yue XJ, Lin JM, Zhang 
WS, Thomas GN. Impact of impaired fasting glucose and impaired 
glucose tolerance on arterial stiffness in an older Chinese 
population: the Guangzhou Biobank Cohort Study-CVD. Metabolism 
2010;59:367-72.
47. Lin JD, Wan HL, Li JC, Wu CZ, Kuo SW, Hsieh CH, Lian WC, 
Lee CH, Kao MT, Pei D. Impaired glucose tolerance and 
impaired fasting glucose share similar underlying pathophy-
siologies. Tohoku J Exp Med 2007;212:349-57.
48. Payne WR, Walsh KJ, Harvey JT, Livy MF, McKenzie KJ, 
Donaldson A, Atkinson MG, Keogh JB, Moss RS, Dunstan DW, 
Hubbard WA. Effect of a low-resource-intensive lifestyle modifica-
tion program incorporating gymnasium-based and home-based 
resistance training on type 2 diabetes risk in Australian adults. 
Diabetes Care 2008;31:2244-50.